ID   RHG20_HUMAN             Reviewed;        1191 AA.
AC   Q9P2F6; A8K8C5; B0YIW7; B0YIW8; Q6RJU1; Q6RJU2; Q6RJU3; Q6RJU5;
AC   Q8IXS1;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   22-JUL-2015, entry version 109.
DE   RecName: Full=Rho GTPase-activating protein 20;
DE   AltName: Full=Rho-type GTPase-activating protein 20;
GN   Name=ARHGAP20; Synonyms=KIAA1391;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), TISSUE
RP   SPECIFICITY, DEVELOPMENTAL STAGE, AND CHROMOSOMAL TRANSLOCATION WITH
RP   BRWD3.
RX   PubMed=15543602; DOI=10.1002/gcc.20131;
RA   Kalla C., Nentwich H., Schlotter M., Mertens D., Wildenberger K.,
RA   Doehner H., Stilgenbauer S., Lichter P.;
RT   "Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia
RT   disrupts two novel genes.";
RL   Genes Chromosomes Cancer 42:128-143(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 436-1185 (ISOFORMS 1/2/3/4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 436-1185 (ISOFORMS 1/2/3/4),
RP   AND VARIANT ASP-632.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION.
RX   PubMed=14532992;
RA   Katoh M., Katoh M.;
RT   "Identification and characterization of human KIAA1391 and mouse
RT   Kiaa1391 genes encoding novel RhoGAP family proteins with RA domain
RT   and ANXL repeats.";
RL   Int. J. Oncol. 23:1471-1476(2003).
CC   -!- FUNCTION: GTPase activator for the Rho-type GTPases by converting
CC       them to an inactive GDP-bound state. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=1ad;
CC         IsoId=Q9P2F6-1; Sequence=Displayed;
CC       Name=2; Synonyms=1be;
CC         IsoId=Q9P2F6-2; Sequence=VSP_024294;
CC       Name=3; Synonyms=1c;
CC         IsoId=Q9P2F6-3; Sequence=VSP_024295;
CC       Name=4; Synonyms=1e, 1d;
CC         IsoId=Q9P2F6-4; Sequence=VSP_024296;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in the brain. Lower
CC       expression is found in lymph nodes. {ECO:0000269|PubMed:15543602}.
CC   -!- DEVELOPMENTAL STAGE: Low expression is found in fetal liver.
CC       {ECO:0000269|PubMed:15543602}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ARHGAP20 may be a
CC       cause of B-cell chronic lymphocytic leukemia (B-CLL).
CC       Translocation t(X;11)(q21;q23) with BRWD3 does not result in
CC       fusion transcripts but disrupts both genes.
CC   -!- SIMILARITY: Contains 1 PH domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ras-associating domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00166}.
CC   -!- SIMILARITY: Contains 1 Rho-GAP domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00172}.
CC   -!- CAUTION: The translocation involving this gene was originally
CC       published as t(X;11)(q13;23), but BRWD3 is localized to Xq21 and
CC       not to Xq13. {ECO:0000305|PubMed:15543602}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH39340.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAH39340.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAA92629.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAF84979.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAF84979.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ARHGAP20ID42979ch11q23.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY496263; AAS45466.1; -; mRNA.
DR   EMBL; AY496264; AAS45467.1; -; mRNA.
DR   EMBL; AY496265; AAS45468.1; -; mRNA.
DR   EMBL; AY496266; AAS45469.1; -; mRNA.
DR   EMBL; AY496267; AAS45470.1; -; mRNA.
DR   EMBL; AB037812; BAA92629.1; ALT_INIT; mRNA.
DR   EMBL; EF444953; ACA05945.1; -; Genomic_DNA.
DR   EMBL; EF444953; ACA05946.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67134.1; -; Genomic_DNA.
DR   EMBL; AK292290; BAF84979.1; ALT_SEQ; mRNA.
DR   EMBL; BC039340; AAH39340.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS31673.1; -. [Q9P2F6-1]
DR   CCDS; CCDS58175.1; -. [Q9P2F6-4]
DR   CCDS; CCDS58176.1; -. [Q9P2F6-2]
DR   CCDS; CCDS58177.1; -. [Q9P2F6-3]
DR   PIR; C59436; C59436.
DR   RefSeq; NP_001245344.1; NM_001258415.1. [Q9P2F6-3]
DR   RefSeq; NP_001245345.1; NM_001258416.1. [Q9P2F6-2]
DR   RefSeq; NP_001245346.1; NM_001258417.1. [Q9P2F6-4]
DR   RefSeq; NP_001245347.1; NM_001258418.1. [Q9P2F6-4]
DR   RefSeq; NP_065860.2; NM_020809.3. [Q9P2F6-1]
DR   RefSeq; XP_006718956.1; XM_006718893.2. [Q9P2F6-1]
DR   UniGene; Hs.6136; -.
DR   PDB; 3MSX; X-ray; 1.65 A; B=351-551.
DR   PDBsum; 3MSX; -.
DR   ProteinModelPortal; Q9P2F6; -.
DR   SMR; Q9P2F6; 360-551.
DR   BioGrid; 121622; 1.
DR   IntAct; Q9P2F6; 1.
DR   STRING; 9606.ENSP00000260283; -.
DR   PhosphoSite; Q9P2F6; -.
DR   BioMuta; ARHGAP20; -.
DR   DMDM; 143458429; -.
DR   PaxDb; Q9P2F6; -.
DR   PRIDE; Q9P2F6; -.
DR   DNASU; 57569; -.
DR   Ensembl; ENST00000260283; ENSP00000260283; ENSG00000137727.
DR   Ensembl; ENST00000524756; ENSP00000432076; ENSG00000137727. [Q9P2F6-3]
DR   Ensembl; ENST00000527598; ENSP00000431399; ENSG00000137727. [Q9P2F6-4]
DR   Ensembl; ENST00000528829; ENSP00000436319; ENSG00000137727. [Q9P2F6-4]
DR   Ensembl; ENST00000533353; ENSP00000436522; ENSG00000137727. [Q9P2F6-2]
DR   GeneID; 57569; -.
DR   KEGG; hsa:57569; -.
DR   UCSC; uc001pky.2; human. [Q9P2F6-3]
DR   UCSC; uc001pkz.2; human. [Q9P2F6-1]
DR   UCSC; uc001pla.2; human. [Q9P2F6-2]
DR   CTD; 57569; -.
DR   GeneCards; GC11M110447; -.
DR   H-InvDB; HIX0010100; -.
DR   HGNC; HGNC:18357; ARHGAP20.
DR   HPA; HPA038458; -.
DR   HPA; HPA038459; -.
DR   MIM; 609568; gene.
DR   neXtProt; NX_Q9P2F6; -.
DR   PharmGKB; PA134963885; -.
DR   eggNOG; NOG271519; -.
DR   GeneTree; ENSGT00530000063299; -.
DR   HOVERGEN; HBG061748; -.
DR   InParanoid; Q9P2F6; -.
DR   OMA; EQLPREM; -.
DR   OrthoDB; EOG7NCV2Q; -.
DR   PhylomeDB; Q9P2F6; -.
DR   TreeFam; TF331062; -.
DR   Reactome; REACT_11051; Rho GTPase cycle.
DR   EvolutionaryTrace; Q9P2F6; -.
DR   GenomeRNAi; 57569; -.
DR   NextBio; 64086; -.
DR   PRO; PR:Q9P2F6; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; Q9P2F6; -.
DR   CleanEx; HS_ARHGAP20; -.
DR   Genevisible; Q9P2F6; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; TAS:Reactome.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR011993; PH-like_dom.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000159; Ras-assoc.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR029071; Ubiquitin-rel_dom.
DR   Pfam; PF00788; RA; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50200; RA; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement;
KW   Complete proteome; GTPase activation; Polymorphism;
KW   Reference proteome; Tumor suppressor.
FT   CHAIN         1   1191       Rho GTPase-activating protein 20.
FT                                /FTId=PRO_0000283086.
FT   DOMAIN       78    180       PH.
FT   DOMAIN      194    295       Ras-associating. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00166}.
FT   DOMAIN      365    551       Rho-GAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00172}.
FT   COMPBIAS    934    973       Ser-rich.
FT   VAR_SEQ       1     36       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15543602}.
FT                                /FTId=VSP_024296.
FT   VAR_SEQ       1     34       MEAMSPQQETLGGQPGRSSSLTGVSRLAGGSCTK -> MTF
FT                                WIIIN (in isoform 2).
FT                                {ECO:0000303|PubMed:15543602}.
FT                                /FTId=VSP_024294.
FT   VAR_SEQ       1     33       MEAMSPQQETLGGQPGRSSSLTGVSRLAGGSCT -> MSAR
FT                                ERQPAL (in isoform 3).
FT                                {ECO:0000303|PubMed:15543602}.
FT                                /FTId=VSP_024295.
FT   VARIANT     522    522       A -> T (in dbSNP:rs7936020).
FT                                /FTId=VAR_031489.
FT   VARIANT     632    632       G -> D (in dbSNP:rs17853925).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031490.
FT   HELIX       367    370       {ECO:0000244|PDB:3MSX}.
FT   HELIX       372    374       {ECO:0000244|PDB:3MSX}.
FT   HELIX       378    390       {ECO:0000244|PDB:3MSX}.
FT   HELIX       391    393       {ECO:0000244|PDB:3MSX}.
FT   TURN        395    399       {ECO:0000244|PDB:3MSX}.
FT   HELIX       404    415       {ECO:0000244|PDB:3MSX}.
FT   HELIX       427    439       {ECO:0000244|PDB:3MSX}.
FT   TURN        442    447       {ECO:0000244|PDB:3MSX}.
FT   HELIX       448    450       {ECO:0000244|PDB:3MSX}.
FT   HELIX       451    456       {ECO:0000244|PDB:3MSX}.
FT   HELIX       457    459       {ECO:0000244|PDB:3MSX}.
FT   STRAND      460    462       {ECO:0000244|PDB:3MSX}.
FT   HELIX       463    474       {ECO:0000244|PDB:3MSX}.
FT   HELIX       479    496       {ECO:0000244|PDB:3MSX}.
FT   HELIX       499    502       {ECO:0000244|PDB:3MSX}.
FT   HELIX       506    517       {ECO:0000244|PDB:3MSX}.
FT   HELIX       526    550       {ECO:0000244|PDB:3MSX}.
SQ   SEQUENCE   1191 AA;  132608 MW;  1837B9DF0655AF41 CRC64;
     MEAMSPQQET LGGQPGRSSS LTGVSRLAGG SCTKKKMKTL AERRRSAPSL ILDKALQKRP
     TTRDSPSASV DTCTFLSSLV CSNRTLLIDG RAELKRGLQR QERHLFLFND LFVVAKIKYN
     NNFKIKNKIK LTDMWTASCV DEVGEGNTNA MKSFVLGWPT VNFVATFSSP EQKDKWLSLL
     QRYINLEKEK DYPKSIPLKI FAKDIGNCAY SKTITVMNSD TANEVINMSL PMLGITGSER
     DYQLWVNSGK EEAPYPLIGH EYPYGIKMSH LRDSALLTPG SKDSTTPFNL QEPFLMEQLP
     REMQCQFILK PSRLAAAQQL SDSGHKTFKR RRSIINWAFW RGSSTHLDNL PSSPTSPMPG
     QLFGISLPNI CENDNLPKPV LDMLFFLNQK GPLTKGIFRQ SANVKSCREL KEKLNSGVEV
     HLDCESIFVI ASVLKDFLRN IPGSIFSSDL YDHWVSVMDQ GNDEEKINTV QRLLDQLPRA
     NVVLLRYLFG VLHNIEQHSS SNQMTAFNLA VCVAPSILWP PASSSPELEN EFTKKVSLLI
     QFLIENCLRI FGEEITSLFR EVSVRCDTRE NASDISCFQL NDSSYDSLEN ELNEDVDAPC
     SDLVKKLGQG SRSMDSVLTL SDYDLDQPEV EGLLTLSDFD LAHSKDEDVQ MKRPLESKPV
     NILVYTKIPL RDHARAPSAM CTPSYLSTAA ANAAKSLRRH RRCSEPSIDY LDSKLSYLRE
     FYQKKLRKSS CDAILSQKDE DYLKQNQPLQ EEGKTCFKQS LVTGTDVSKK NATTQNTKKK
     SLSGSEGNHV KLFPKSKPVA ISVASYSPMS SQDHSKNQPF DVNTSGYSPP HTADALKGPR
     THRRCSEPNI EDQNRKLTYL RGIYSKKQHK TSCEAGLLHG EEDYLKRHKS LQMEGQKLIN
     QSLVMGIEVG KSSATNQNTE KVLPPRLNLC PRTSYSSLSS PGTSPSGSSV SSQDSAFSQI
     SEHSVFTPTE TSSPIDCTFQ AQRKREDLSP DFSNASHVSG MPGPSSGQAC SRPAYTKKDT
     MEWHSQMHSV TLHPSTWLRN GVASLKNWSL KKKAKAARPE EEKIASPKGP LEPPPHASGV
     PEANSLQEEQ KDLPLRAAEG LSPVQSAQRC SSSPFQDSER HCSSPFSLVE SRLKLCMKSH
     EEIEPGSQSS SGSLPWERAS ASSWTLEDAT SPDSGPTVVC DIEDRYLTKD I
//
